• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Hologic's Charts Are Looking a Little 'Touch and Go'

For now it looks like HOLX will try to move higher.
By BRUCE KAMICH
Apr 04, 2022 | 01:24 PM EDT
Stocks quotes in this article: HOLX

Hologic (HOLX) is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health.

 
The stock of Hologic was downgraded from "buy" to "hold" by Evercore on Monday. Let's check out the charts. In our February 4 review of HOLX we wrote that "The charts of HOLX are still pointed up. Sticking to my late December recommendation, I would wait for a downward reaction over the next several weeks to buy; the trigger could be rising interest rates or the stronger dollar or something entirely different."
 
Let's check the charts again.
 
In this daily bar chart of HOLX, below, we can see that prices dipped after our February 4th review allowing buyers to acquire shares at a better price. Prices subsequently rallied but ran into some selling interest (resistance) in the $76-$78 area - the zone where prices stalled in December. HOLX is trading above the rising 50-day moving average line and above the rising 200-day line.
 
The On-Balance-Volume (OBV) line shows a rise the past two months. The Moving Average Convergence Divergence (MACD) oscillator is above the zero line but has narrowed in recent days. 
 
 
In this weekly Japanese candlestick chart of HOLX, below, we see a mixed picture. Prices have made a sideways consolidation in the form of a triangle. Prices look like they had turned upwards to break out of the pattern but the advance appears to have stalled with a spinning top formation. Prices are not far above the rising 40-week moving average line.
 
The weekly OBV line shows a decline to early March with recent improvement. The MACD oscillator looks like it has turned upward just slightly above the zero line. 
 
 
In this daily Point and Figure chart of HOLX, below, we can see a potential upside price target in the $89 area. A trade at $79 is needed to refresh the uptrend.
 
 
In this weekly Point and Figure chart of HOLX, below, we can see a price target in the $96 area.
 
Bottom line strategy: For now it looks like HOLX will try to move higher. Risk to $71 and add to longs or go long on strength above $79.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Analyst Actions

More from Investing

Bearish Bets: 3 Stocks You Should Consider Shorting This Week

Bob Lang
Jul 3, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

Let's Shine a Light on Lucid Motors as It Slides Downhill

Brad Ginesin
Jul 2, 2022 1:00 PM EDT

LCID's market cap has been deflated, so is it now a bargain, or can it slip further?

Stop Wishing, Hoping and Praying and Take Control of Your Investing

James "Rev Shark" DePorre
Jul 2, 2022 10:00 AM EDT

The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.

If You've Got Time, These Three Dividend Aristocrats Should Pay Off

Bob Ciura
Jul 2, 2022 7:30 AM EDT

There high-growth dividend stocks will be here over the long haul.

Welcome to Second Semester on Wall Street, Here's How to Make the Grade

Jim Collins
Jul 1, 2022 4:36 PM EDT

Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • 07:59 PM EDT PAUL PRICE

    Very Good Quarterly Numbers From Bassett Furniture (BSET)

    Bassett Furniture blew right through analysts es...
  • 04:41 PM EDT PAUL PRICE

    First-Half Results - Putrid; Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 mark...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login